Risk factors for Cervical Intraepithelial Neoplasia in HIV-infected women on antiretroviral treatment in Côte d'Ivoire, West Africa

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Jaquet, Antoine ^a,b   Horo, Apollinaire ^c   Ekouevi, Didier K ^a,b,c   Toure, Badian ^c   Coffie, Patrick A ^c   Effi, Benjamin ^c   Lenaud, Severin ^c   Messou, Eugene ^d   Minga, Albert ^e   Sasco, Annie J ^a,b   Dabis, François ^a,b   Zannou, Djimon Marcel ^f   Koumakpaï, Sikiratou ^f   Drabo, Joseph ^g   Sawadogo, Adrien Bruno ^h   Yé, Diarra ^f   Bosse, Clarisse Amani ^f   Chenal, Henri ^f   Eholié, Serge Paul ^c   Koule, Serge Olivier ^c   Aka, Edmond Addi ^f   Pety, Touré ^f   Kouakou, Kouadio ^f   Folquet, Madeleine Amorissani ⁱ   Eboua, Tanoh François ^j   Renner, Lorna ^f   Wejse, Christian ^k   Da Silva, Zacarias José ^k   Maïga, Moussa Y ^f   Traore, Hamar Alassane ^f   Minta, Daouda ^f   Dicko, Fatoumata ^f   Charurat, Man ^f   Ajayi, Samuel ^l   Benson, Okwara ^m   Adebamowo, Clément ^m   Seydi, Moussa ⁿ   Sy, Haby Signate ^f   Patassi, Akessiwe ^o   Lawson Evi, Annette Koko ^o   Bissagnene, Emmanuel ^f   Arrivé, Elise ^f   Leroy, Valériane ^f   Lewden, Charlotte ^f   Gottlieb, Geoffrey S ^f   more..

^a UNIVERSITÉ DE BORDEAUX   (France)

^b INSERM   (France)

^c CENTRE HOSPITALIER UNIVERSITAIRE DE TREICHVILLE   (Côte d’Ivoire)

^d ACONDA   (Côte d’Ivoire)

^e Centre Médical de Suivi de Donneurs de Sang CNTS PRIMO CI   (Côte d’Ivoire)

^f CePReF ACONDA ^*

^g Service d'Urologie   (Burkina Faso)

^h CHU Souro Sanou   (Burkina Faso)

ⁱ CHU de Cocody   (Côte d’Ivoire)

^j CHU Yopougon   (Côte d’Ivoire)

^k BANDIM HEALTH PROJECT   (Guinea-Bissau)

^l UATH   (Nigeria)

^m UBTH   (Nigeria)

ⁿ SMIT CHU Fann   (Senegal)

^o CHU Tokoin Sylvanus Olympio   (Togo)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICA; AGED; ANTIVIRAL THERAPY; ARTICLE; CANCER GRADING; CANCER RISK; CANCER SCREENING; CD4 LYMPHOCYTE COUNT; COLPOSCOPY; CONVALESCENCE; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS 2 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE STATUS; MAJOR CLINICAL STUDY; RISK ASSESSMENT; RISK FACTOR; UTERINE CERVIX CARCINOMA IN SITU; WOMEN'S HEALTH;

ADULT; ANTI-RETROVIRAL AGENTS; CD4 LYMPHOCYTE COUNT; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; COLPOSCOPY; COTE D'IVOIRE; FEMALE; HIV; HIV INFECTIONS; HUMANS; MIDDLE AGED; RISK FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 84897140951     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0090625     Document Type: Article

References (27)

1. UNAIDS (2013) Global report: UNAIDS report on the global AIDS epidemic. Geneva. http://www.unaids.org/en/media/unaids/contentassets/documents/ epidemiology/2013/gr2013/UNAIDS-Global-Report-2013-en.pdf last accessed 12/09/13.
2. Johnson LF, Mossong J, Dorrington RE, Schomaker M, Hoffmann CJ, et al. (2013) Life expectancies of South African adults starting antiretroviral treatment: collaborative analysis of cohort studies. PLoS Med 10: e1001418.
3. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, et al. (2013) GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer. Available from: http://globocan.iarc.fr, accessed on 20/01/2014.
4. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, et al. (2003) Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348: 518-527. (Pubitemid 36159887)
5. Adjorlolo-Johnson G, Unger ER, Boni-Ouattara E, Toure-Coulibaly K, Maurice C, et al. (2010) Assessing the relationship between HIV infection and cervical cancer in Cote d'Ivoire: a case-control study. BMC Infect Dis 10: 242.
6. Mbulaiteye SM, Katabira ET, Wabinga H, Parkin DM, Virgo P, et al. (2006) Spectrum of cancers among HIV-infected persons in Africa: the Uganda AIDS-Cancer Registry Match Study. Int J Cancer 118: 985-990. (Pubitemid 43157675)
7. Stein L, Urban MI, O'Connell D, Yu XQ, Beral V, et al. (2008) The spectrum of human immunodeficiency virus-associated cancers in a South African black population: results from a case-control study, 1995-2004. Int J Cancer 122: 2260-2265. (Pubitemid 351542329)
8. Horo A, Jaquet A, Ekouevi DK, Toure B, Coffie PA, et al. (2012) Cervical cancer screening by visual inspection in Cote d'Ivoire, operational and clinical aspects according to HIV status. BMC Public Health 12: 237.
9. Sankaranarayanan R, Wesley RS (2003) A practical manual on visual screening for cervical neoplasia. Lyon: IARC Press and World Health Organization Distribution and Sales: pp 1-49.
10. Arbyn M, Sankaranarayanan R, Muwonge R, Keita N, Dolo A, et al. (2008) Pooled analysis of the accuracy of five cervical cancer screening tests assessed in eleven studies in Africa and India. Int J Cancer 123: 153-160. (Pubitemid 351705203)
11. Agaba PA, Thacher TD, Ekwempu CC, Idoko JA (2009) Cervical dysplasia in Nigerian women infected with HIV. Int J Gynaecol Obstet 107: 99-102.
12. Firnhaber C, Van Le H, Pettifor A, Schulze D, Michelow P, et al. (2010) Association between cervical dysplasia and human papillomavirus in HIV seropositive women from Johannesburg South Africa. Cancer Causes Control 21: 433-443.
13. Parham GP, Sahasrabuddhe VV, Mwanahamuntu MH, Shepherd BE, Hicks ML, et al. (2006) Prevalence and predictors of squamous intraepithelial lesions of the cervix in HIV-infected women in Lusaka, Zambia. Gynecol Oncol 103: 1017-1022. (Pubitemid 44830069)
14. Fife KH, Wu JW, Squires KE, Watts DH, Andersen JW, et al. (2009) Prevalence and persistence of cervical human papillomavirus infection in HIV-positive women initiating highly active antiretroviral therapy. J Acquir Immune Defic Syndr 51: 274-282.
15. Jaquet A, Horo A, Charbonneau V, Ekouevi DK, Roncin L, et al. (2012) Cervical human papillomavirus and HIV infection in women of child-bearing age in Abidjan, Cote d'Ivoire, 2010. Br J Cancer 107: 556-563.
16. Sahasrabuddhe VV, Mwanahamuntu MH, Vermund SH, Huh WK, Lyon MD, et al. (2007) Prevalence and distribution of HPV genotypes among HIV-infected women in Zambia. Br J Cancer 96: 1480-1483. (Pubitemid 46685795)
17. Strickler HD, Burk RD, Fazzari M, Anastos K, Minkoff H, et al. (2005) Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women. J Natl Cancer Inst 97: 577-586. (Pubitemid 40723785)
18. Anastos K, Hoover DR, Burk RD, Cajigas A, Shi Q, et al. (2010) Risk factors for cervical precancer and cancer in HIV-infected, HPV-positive Rwandan women. PLoS One 5: e13525.
19. Huchko MJ, Leslie H, Sneden J, Maloba M, Abdulrahim N, et al. (2014) Risk factors for cervical precancer detection among previously unscreened HIV-infected women in Western Kenya. Int J Cancer 134: 740-745.
20. de Andrade AC, Luz PM, Velasque L, Veloso VG, Moreira RI, et al. (2011) Factors associated with colposcopy-histopathology confirmed cervical intraepithelial neoplasia among HIV-infected women from Rio De Janeiro, Brazil. PLoS One 6: e18297.
21. Sahasrabuddhe VV, Bhosale RA, Joshi SN, Kavatkar AN, Nagwanshi CA, et al. (2010) Prevalence and predictors of colposcopic-histopathologically confirmed cervical intraepithelial neoplasia in HIV-infected women in India. PLoS One 5: e8634.
22. De Vuyst H, Mugo NR, Chung MH, McKenzie KP, Nyongesa-Malava E, et al. (2012) Prevalence and determinants of human papillomavirus infection and cervical lesions in HIV-positive women in Kenya. Br J Cancer 107: 1624-1630.
23. Minkoff H, Zhong Y, Burk RD, Palefsky JM, Xue X, et al. (2010) Influence of adherent and effective antiretroviral therapy use on human papillomavirus infection and squamous intraepithelial lesions in human immunodeficiency virus-positive women. J Infect Dis 201: 681-690.
24. Simen-Kapeu A, La Ruche G, Kataja V, Yliskoski M, Bergeron C, et al. (2009) Tobacco smoking and chewing as risk factors for multiple human papillomavirus infections and cervical squamous intraepithelial lesions in two countries (Cote d'Ivoire and Finland) with different tobacco exposure. Cancer Causes Control 20: 163-170.
25. Munoz N, Franceschi S, Bosetti C, Moreno V, Herrero R, et al. (2002) Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study. Lancet 359: 1093-1101. (Pubitemid 34270732)
26. Hawes SE, Critchlow CW, Faye Niang MA, Diouf MB, Diop A, et al. (2003) Increased risk of high-grade cervical squamous intraepithelial lesions and invasive cervical cancer among African women with human immunodeficiency virus type 1 and 2 infections. J Infect Dis 188: 555-563. (Pubitemid 37011808)
27. La Ruche G, Ramon R, Mensah-Ado I, Bergeron C, Diomande M, et al. (1998) Squamous intraepithelial lesions of the cervix, invasive cervical carcinoma, and immunosuppression induced by human immunodeficiency virus in Africa. Dyscer-CI Group. Cancer 82: 2401-2408. (Pubitemid 28283447)